Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
暂无分享,去创建一个
A. Gotto | C. Cannon | P. Barter | M. Davidson | E. Brinton | H. Dansky | Y. Mitchel | U. Kher | Sukrut Shah | T. B. Ashraf | C. Mccrary Sisk